Intrarosa™ (prasterone) – New drug approval
November 17, 2016 – The FDA announced the approval of Endoceutics’ Intrarosa (prasterone), for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy (VVA), due to menopause.
Download PDF
